[1]赵祖桉,靳亚阁,仝 壮,等.全球视角下中国居民缺血性心脏病疾病负担 及其影响因素分析[J].卫生经济研究,2025,42(09):53-57.
 ZHAO Zuan,JIN Yage,TONG Zhuang,et al.Study on the Disease Burden of Ischemic Heart Disease and its Influencing Factors among Chinese Residents from a Global Perspective[J].Journal Press of Health Economics Research,2025,42(09):53-57.
点击复制

全球视角下中国居民缺血性心脏病疾病负担 及其影响因素分析

卫生经济研究[ISSN:1004-7778/CN:33-1056/F]

卷:
42
期数:
2025年09期
页码:
53-57
栏目:
成本与费用
出版日期:
2025-08-28

文章信息/Info

Title:
Study on the Disease Burden of Ischemic Heart Disease and its Influencing Factors among Chinese Residents from a Global Perspective
作者:
赵祖桉1靳亚阁1仝 壮12张 亮1原瑞霞12
1.郑州大学第一附属医院,河南 郑州 450000
2.河南省医学大数据研究院,河南 郑州 450000
Author(s):
ZHAO Zuˊan JIN Yage TONG Zhuang ZHANG Liang YUAN Ruixia
The First Affiliated Hospital of Zhengzhou University, Zhengzhou Henan 450000, China
关键词:
缺血性心脏病疾病负担年龄标准化率斜率指数危险因素
Keywords:
ischemic heart disease disease burden age-standardized rate slope index risk factors
分类号:
R19
文献标志码:
A
摘要:
目的:分析全球视角下中国居民缺血性心脏病 (IHD)的疾病负担及其影响因素。方法:通过计算斜率指数和集中指数,量化全球IHD疾病负担分布的差异;利用年龄标准化率及其年度变化百分比,描述IHD疾病负担特征和变化趋势。结果:1990—2021年,我国IHD患者的标准化发病率、患病率、死亡率及伤残调整寿命年率均呈现上升趋势,颗粒物污染、吸烟和高钠饮食是主要的危险因素。结论:从全球视角看,我国正承受着IHD疾病负担大和流行率持续上升的双重压力,应加大防控力度,加强重点人群筛查和危险因素控制。
Abstract:
Objective To analyze the disease burden of ischemic heart disease(IHD) and its influencing factors among Chinese residents from a global perspective. Methods The slope indices and concentration indices were used to quantify global disparities in the distribution of IHD disease burden. Age-standardized rates and estimated annual percentage changes were used to describe the characteristics and trends of IHD disease burden. Results From 1990 to 2021, standardized incidence rate, prevalence rate, mortality rate, and disability-adjusted life year rate of IHD patients in China all showed an upward trend. Particulate matter pollution, smoking, and high-sodium diet were identified as the leading risk factors. Conclusion From a global perspective, China is facing the dual pressures of a high disease burden and a continuously rising prevalence rate of IHD. It is crucial to strengthen prevention and control measures, enhance screening among key populations, and manage risk factors.

参考文献/References:

[1] Montone R A,Camilli M,Calvieri C,et al.Exposome in Ischaemic Heart Disease:beyond traditional risk factors[J].Eur Heart J,2024,45(06):419-438.
[2] Solola Nussbaum S,Henry S,Yong C M,et al.Sex-specific considerations in the presentation,diagnosis,and management of Ischemic Heart Disease:JACC Focus Seminar 2/7[J].J Am Coll Cardiol,2022, 79(14):1398-1406.
[3] Diseases GBD,Injuries C.Global incidence,prevalence, years lived with disability(YLDs),disability-adjusted life-years(DALYs), and healthy life expectancy(HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021:a systematic analysis for the Global Burden of Disease Study 2021[J].Lancet,2024,403(10440):2133-2161.
[4] Collaborators GCoD.Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990-2021:a systematic analysis for the Global Burden of Disease Study 2021[J].Lancet,2024,403(10440): 1988.
[5] Xie J,Wang M,Long Z,et al.Global burden of Type 2 Diabetes in adolescents and young adults,1990-2019:systematic analysis of the Global Burden of Disease Study 2019[J].BMJ,2022,379:e072385.
[6] Cheng L,Wang Z,Li R,et al.The global burden, trends and cross-country inequalities of female breast and gynaecologic cancers:a population based study[J].BJOG,2025,132(01):55-63.
[7] Celermajer D S,Chow C K,Marijon E,et al.Cardiovascular disease in the developing world:prevalences, patterns, and the potential of early disease detectio[J].J Am Coll Cardiol,2012,60(14):1207-1216.
[8] Sterpetti A V,Gabriele R,Iannone I,et al.Trends towards increase of cardiovascular diseases mortality in USA:a comparison with Europe and the importance of preventive care[J].Curr Probl Cardiol,2024,49(04):102459.
[9] Ohira T,Eguchi E,Hayashi F,et al.Epidemiology of cardiovascular disease in Japan: an overview study[J].J Cardiol,2024,83(03):191-200.
[10] Ma L Y,Wang X D,Liu S,et al.Prevalence and risk factors of stroke in a rural area of northern China:a 10-year comparative study[J].Aging Clin Exp Res,2022,34(05):1055-1063.
[11] Wang B,Li P,He F,et al.Spatiotemporal variations in Ischemic Heart Disease mortality and related risk factors in China between 2010 and 2015:a multilevel analysis[J].BMC Public Health,2021,21(01):9.
[12] Ji H,Kwan A C,Chen M T,et al.Sex differences in myocardial and vascular aging[J].Circ Res,2022,130(04):566-577.
[13] Roth G A,Mensah G A,Johnson C O,et al.Global burden of cardiovascular diseases and risk factors, 1990-2019:update from the GBD 2019 study[J].J Am Coll Cardiol,2020,76(25):2982-3021.
[14] Moran A,Gu D, Zhao D,et al.Future cardiovascular disease in China:Markov model and risk factor scenario projections from the Coronary Heart Disease policy model-China[J].Circ Cardiovasc Qual Outcomes,2010,3(03):243-252.
[15] Sliwa K, Viljoen C A,Stewart S,et al.Cardiovascular disease in low-and middle-income countries associated with environmental factors[J].Eur J Prev Cardiol,2024,31(06):688-697.
[16] Kaufman J D,Elkind M S V,Bhatnagar A,et al.Guidance to reduce the cardiovascular burden of ambient air pollutants:a policy statement from the American Heart Association[J].Circulation,2020,142(23):e432-e447.
[17] Zhang S,Routledge M N.The contribution of PM(2.5) to cardiovascular disease in China[J].Environ Sci Pollut Res Int,2020,27(30): 37502-37513.
[18] Yusuf S,Joseph P,Rangarajan S,et al.Modifiable risk factors, cardiovascular disease, and mortality in 155 722 individuals from 21 high-income,middle-income,and low-income countries (PURE):a prospective cohort study[J].Lancet,2020,395(10226):795-808.
[19] Collaborators GBDT.Spatial,temporal,and demographic patterns in prevalence of smoking tobacco use and attributable disease burden in 204 countries and territories,1990-2019:a systematic analysis from the Global Burden of Disease Study 2019[J].Lancet,2021,397(10292):2337-2360.
[20] Du S,Wang H, Zhang B,Popkin BM.Dietary potassium intake remains low and sodium intake remains high, and most sodium is derived from home food preparation for Chinese adults,1991-2015 trends[J].J Nutr,2020, 150(05):1230-1239.
[21] Chobufo M D,Singla A,Rahman E U,et al.Temporal trends in atherosclerotic cardiovascular disease risk among U.S.adults.Analysis of the National Health and Nutrition Examination Survey,1999-2018[J].Eur J Prev Cardiol,2022,29(18):2289-2300.

相似文献/References:

[1]程亮亮,高明月,邱培媛,等.西部民族地区新农合运行现状分析[J].卫生经济研究,2016,(10):29.
[2]张礼亮,张婧怡,田佳帅,等.肺结核患者疾病负担现状及影响因素研究[J].卫生经济研究,2024,41(05):36.
 ZHANG Liliang,ZHANG Jingyi,TIAN Jiashuai,et al.Study on the Current Situation and Influencing Factors of the Disease Burden in Patients with Pulmonary Tuberculosis[J].Journal Press of Health Economics Research,2024,41(09):36.
[3]曹逸钦,张 悦,王艳艳,等.消化系统癌症患者经济毒性的研究进展[J].卫生经济研究,2025,42(02):41.
 CAO Yiqin,ZHANG Yue,WANG Yanyan,et al.Research Progress on Financial Toxicity in Patients with Digestive System Cancer[J].Journal Press of Health Economics Research,2025,42(09):41.
[4]梁盛兴,邹俐爱,邱 恒,等.1990—2021年中国归因于高BMI的慢性肾病疾病负担研究[J].卫生经济研究,2025,42(04):42.
 LIANG Shengxing,ZOU Liai,QIU Heng,et al.Study on the Disease Burden of Chronic Kidney Disease Attributed to High BMI in China from 1990 to 2021[J].Journal Press of Health Economics Research,2025,42(09):42.
[5]宫琳婧,李佳佳.失智症疾病负担及保障政策的国际比较[J].卫生经济研究,2025,42(09):34.
 GONG Linjing,LI Jiajia.International Comparison of the Disease Burden and Protection Policies for Dementia[J].Journal Press of Health Economics Research,2025,42(09):34.
[6]李铭轩,肖晓燕,原 彰.中国归因于高BMI的高血压性心脏病疾病负担研究[J].卫生经济研究,2025,42(11):38.
 LI Mingxuan,XIAO Xiaoyan,YUAN Zhang.Study on the Disease Burden of Hypertensive Heart Disease Attributable to High BMI in China[J].Journal Press of Health Economics Research,2025,42(09):38.

更新日期/Last Update: 2025-08-28